Equities

Regencell Bioscience Holdings Ltd

RGC:NAQ

Regencell Bioscience Holdings Ltd

Actions
  • Price (USD)4.18
  • Today's Change0.71 / 20.46%
  • Shares traded1.89k
  • 1 Year change-84.34%
  • Beta--
Data delayed at least 15 minutes, as of Mar 28 2024 16:43 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Regencell Bioscience Holdings Ltd is a bioscience company that focuses on research, development and commercialization of traditional Chinese medicine (TCM) for the treatment of neurocognitive disorders and degeneration, specifically attention deficit and hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). The Company launches three liquid based standardized TCM formulae candidates for mild, moderate and severe ADHD and ASD patients.

  • Revenue in USD (TTM)0.00
  • Net income in USD-7.45m
  • Incorporated2014
  • Employees12.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
SensaSure Technologies Inc1.15k-746.37k42.26m1.00------36,749.47-0.0132-0.01320.00002-0.02120.0135--0.79861,150.00-891.64-----------66,024.35-----92.16-----31.15--17.62------
Viracta Therapeutics Inc0.00-51.06m42.41m40.00--3.28-----1.32-1.320.000.46860.00----0.00-66.88-86.35-97.91-106.38-------11,853.94---141.210.5798-------3.78------
Tiziana Life Sciences Ltd - ADR0.00-15.40m42.65m9.00--2.18-----0.1496-0.14960.000.19140.00----0.00-40.89---50.40-------------2,083.710.0183------34.25------
Benson Hill Inc473.34m-111.25m43.26m270.00--0.5028--0.0914-0.5914-0.61312.520.41291.2210.2714.811,753,096.00-28.68---38.28--4.993.18-23.50-40.730.9166-2.330.4509--24.16156.43-11.58--63.78--
Candel Therapeutics Inc31.00k-31.93m44.54m76.00--1.93--1,436.66-1.10-1.100.00110.79610.0005----407.89-47.28---53.73-------102,990.30-----1,199.130.479--0.00--47.97------
Calcimedica Inc0.00-37.61m44.71m8.00--1.96-----30.15-30.150.002.140.00----0.00-122.91---139.94--------------0.00------0.603------
Aptorum Group Ltd1.20m-13.40m45.08m18.00--2.06--37.57-3.64-3.640.32344.220.062474.8717.3666,656.11-80.15-42.74-68.67-46.937.33-2.90-1,283.55-1,477.581.32-94.530.0066---15.95--60.88---42.83--
Regencell Bioscience Holdings Ltd0.00-7.45m45.15m12.00--2.65-----0.5863-0.58630.001.310.00----0.00-82.73---113.11--------------0.00------21.15------
Protara Therapeutics Inc0.00-40.42m45.74m26.00--0.6654-----3.57-3.570.006.010.00----0.00-42.05-37.02-44.82-38.29------------0.00------38.71---17.67--
Estrella Immunopharma Inc0.00-2.16m45.76m----4.37-----1.90-1.900.000.28610.00-------5.92---7.86--------------0.00-------302.11------
Bolt Biotherapeutics Inc7.88m-69.20m46.52m100.00--0.4125--5.91-1.83-1.830.20832.960.0406----78,760.00-35.71-48.32-40.23-54.03-----878.58-2,267.00----0.00--37.48--21.45---6.61--
Eyenovia Inc3.79k-27.26m46.74m57.00--4.99--12,332.95-0.6639-0.66390.000090.19760.0001--0.003166.49-91.15-80.31-119.11-117.700.00---719,290.30-680.952.16-15.140.6135------2.68--152.20--
Dyadic International Inc2.96m-6.87m46.96m7.00--6.14--15.89-0.2392-0.23920.10290.26560.2416--9.05---56.14-28.07-66.60-29.5521.1719.50-232.41-465.37----0.00--21.9031.0425.52------
Lexaria Bioscience Corp279.75k-6.09m47.01m5.00--10.22--168.04-0.8429-0.84290.03990.36290.0569--4.0855,950.00-124.56-95.67-120.95-96.5892.6676.98-2,190.62-1,612.76---131.800.00---11.43-12.198.31------
Cara Therapeutics Inc20.97m-118.51m47.50m55.00--0.8294--2.27-2.19-2.190.38721.050.13612.376.96381,236.40-76.94-35.76-91.50-40.8270.56---565.21-162.104.43--0.00---49.929.26-38.65--100.66--
Bright Green Corp0.00-9.57m47.89m23.00--3.03-----0.0547-0.05470.000.08490.00----0.00-43.72---60.11-------------42.170.00-------1,010.70------
Data as of Mar 28 2024. Currency figures normalised to Regencell Bioscience Holdings Ltd's reporting currency: US Dollar USD

Institutional shareholders

0.13%Per cent of shares held by top holders
HolderShares% Held
UBS Securities LLCas of 31 Dec 202316.05k0.12%
BlackRock Financial Management, Inc.as of 31 Dec 2023238.000.00%
Qube Research & Technologies Ltd.as of 31 Dec 202313.000.00%
Tower Research Capital LLCas of 31 Dec 20230.000.00%
Morgan Stanley Smith Barney LLC (Investment Management)as of 31 Dec 20230.000.00%
More ▼
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.